Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.
Avouac J, Konstantinova I, Guignabert C, Pezet S, Sadoine J, Guilbert T, Cauvet A, Tu L, Luccarini JM, Junien JL, Broqua P, Allanore Y.
Avouac J, et al.
Ann Rheum Dis. 2017 Nov;76(11):1931-1940. doi: 10.1136/annrheumdis-2016-210821. Epub 2017 Aug 11.
Ann Rheum Dis. 2017.
PMID: 28801346